Workflow
Nasdaq(NDAQ)
icon
Search documents
Nasdaq 100 Forecast: Tesla Gains, Nvidia's AI Chips Face Scrutiny
FX Empire· 2024-11-18 15:14
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Caravelle International Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
Prnewswire· 2024-11-18 14:00
HONG KONG, Nov. 18, 2024 /PRNewswire/ -- Caravelle International Group (NASDAQ: HTCO), a global ocean technology company, today announced that it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules.The Company had previously announced on July 31, 2024, that it was notified by Nasdaq on July 26, 2024 ...
Nasdaq 100: Tesla Rallies, Nvidia Stumbles; Market Awaits Earnings Results
FX Empire· 2024-11-18 13:36
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Sharps Regains Nasdaq Listing Compliance
GlobeNewswire News Room· 2024-11-18 13:00
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that on November 13, 2024, the Company was notified by the Nasdaq Stock Market (“Nasdaq”) that the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Stock Market, as set forth in Nasdaq Listing ...
Nasdaq 100 Infighting Makes QQQM, QQQ Risky Bets (Technical Analysis)
Seeking Alpha· 2024-11-18 11:57
Sometimes I write articles which are pre-planned days or weeks in advance. Not this one. This one came to me on Sunday, as I was prepping for the week and scanning tons of charts to see what the story the marketI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden YARP Portfolio, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income investing. I've been charting investments since th ...
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
GlobeNewswire News Room· 2024-11-18 11:00
IM8 Launch and Market Entry - IM8 marks a bold entry into the $187 billion global consumer health market [1] - The brand is launched in partnership with David Beckham, a strategic investor in Prenetics and Co-Founding Partner for IM8 [1] - IM8 is now available at www.IM8health.com, shipping to 31 countries including free shipping to the US, UK, Canada, Singapore, and Hong Kong [2] IM8 Products and Features - IM8 introduces two premium products: Daily Ultimate Essentials and Daily Ultimate Longevity [2] - Daily Ultimate Essentials is an all-in-one powder with 92 nutrient-rich ingredients, designed to replace 16 separate daily supplements [4] - Daily Ultimate Longevity is a daily capsule for cellular rejuvenation and healthy aging, powered by patent-pending Cell Rejuvenation Technology 8 (CRT8)® [7] - Both products are Vegan, non-GMO, and contain no artificial flavors, colors, or sweeteners [7] Clinical Trials and Efficacy - In a 12-week randomized clinical trial, IM8 Daily Ultimate Essentials demonstrated significant benefits: 93% of participants felt a boost in energy, 73% experienced greater endurance, 60% felt less bloated, and 60% saw visible changes in hair, skin, and nail health [5] - The study is ongoing, with early findings showcasing the powerful impact of IM8's 92 nutrient-rich ingredients [6] Pricing and Launch Offers - Daily Ultimate Essentials: $79 for subscription ($99 one-time) [13] - Daily Ultimate Longevity: $75 for subscription ($95 one-time) [13] - The Beckham Stack: $129 for subscription ($154 one-time), combining both products [13] - Launch offer includes a free welcome kit with a signature red cup ($28 value) and five free travel sachets ($18 value) [12] Scientific Advisory Board - IM8's Scientific Advisory Board includes experts from academia, medicine, and space science, ensuring unmatched efficacy and innovation [10] - Notable members include Dr. Dawn Mussallem (Mayo Clinic), Dr. James Green (Former Chief Scientist, NASA), and Prof. Suzanne Devkota (Cedars-Sinai Medical Center) [11] Prenetics and IM8 Strategy - IM8 is part of Prenetics' consumer initiative, alongside Europa, a top sports nutrition distributor in the US [15] - Prenetics' clinical division includes Insighta, a $200 million joint venture focused on multi-cancer early detection technologies [15] - The company aims to enhance global health through science, with IM8 representing a new standard in optimal daily nutrition [9][10] David Beckham's Role and Influence - David Beckham is a Co-Founding Partner of IM8, leveraging his personal health and wellness journey to promote the brand [3] - Beckham's involvement adds credibility and global appeal to IM8, aligning with his commitment to health and wellness [3][16]
International Petroleum Corporation Announces Completion of Annual Normal Course Issuer Bid
GlobeNewswire News Room· 2024-11-18 09:00
TORONTO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC has completed the current normal course issuer bid / share repurchase program (NCIB), purchasing for cancellation 8,342,119 IPC common shares between December 2023 and November 2024, representing approximately 6.5% of the total outstanding common shares at the commencement of the NCIB. As previously announced, the IPC Board of Directors has app ...
International Petroleum Corporation Announces Completion of Annual Normal Course Issuer Bid
GlobeNewswire News Room· 2024-11-18 09:00
International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC has completed the current normal course issuer bid / share repurchase program (NCIB), purchasing for cancellation 8,342,119 IPC common shares between December 2023 and November 2024, representing approximately 6.5% of the total outstanding common shares at the commencement of the NCIB. As previously announced, the IPC Board of Directors has approved, subject to acceptance by the Toronto ...
District Applies to List on the Nasdaq First North Growth Market in Sweden
Newsfile· 2024-11-18 07:00
District Applies to List on the Nasdaq First North Growth Market in SwedenNovember 18, 2024 2:00 AM EST | Source: District Metals Corp.Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is excited to announce that it has initiated the process of applying for a secondary listing of its shares on the Nasdaq First North Growth Market in Sweden ("Nasdaq First North"). The Company's objectiv ...
Medicus Pharma makes debut on Nasdaq raising $4M to advance skin cancer trial - ICYMI
Proactiveinvestors NA· 2024-11-16 14:53
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...